Katja Mercer-Chalmers-Bender (Katja Mercer-Chalmers Bender)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Venues

Drug testing and analysis

International journal of legal medicine

Forensic toxicology

Analytical and bioanalytical chemistry

University of Basel, Faculty of Medicine

Max Planck Institute for Polymer Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Basel, Faculty of Medicine May 01 2017

Switzerland

Head of Forensic Chemistry and Toxicology :: Institute of Forensic Medicine Basel

University Hospital Cologne Jul 01 2004 - Apr 30 2017

Germany

Deputy Head of Forensic Toxicology :: Institute of Legal Medicine Cologne

Max Planck Institut of Polymer Research

Germany

PhD-student :: Material Science

Stanford University

United States

Visiting researcher during PhD :: Chemical Engineering

Education History

Max Planck Institute for Polymer Research

Germany

PHD :: Material Sciences

Publications

Laura Egloff, Priska Frei, Kathrin Gerlach, Katja Mercer-Chalmers-Bender, Eva Scheurer
Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability - a randomized clinical trial. International journal of legal medicine (2023)
Manuela Carla Monti, Jill Zeugin, Konrad Koch, Natasa Milenkovic, Eva Scheurer, Katja Mercer-Chalmers-Bender
Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services. Drug testing and analysis 14 (6) (2022)
Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, Katja Mercer-Chalmers-Bender, Priska Frei, Wilhelm Ruppen, Tobias Schneider
Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II). Pain 163 (10) (2022)
Manuela Carla Monti, Priska Frei, Sophie Weber, Eva Scheurer, Katja Mercer-Chalmers-Bender
Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis. Analytical and bioanalytical chemistry 414 (13) (2022)
Priska Frei, Stephanie Frauchiger, Eva Scheurer, Katja Mercer-Chalmers-Bender
Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on-line solid phase extraction. Drug testing and analysis 14 (7) (2022)
Patrick Dahm, Andreas Thomas, Markus A Rothschild, Mario Thevis, Katja Mercer-Chalmers-Bender
Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models. Forensic toxicology 40 (2) (2021)
Manuela Carla Monti, Eva Scheurer, Katja Mercer-Chalmers-Bender
Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA. Metabolites 11 (8) (2021)
Ulf Meier, Katja Mercer-Chalmers-Bender, Eva Scheurer, Franz Dussy
Development, validation, and application of an LC-MS/MS method for mitragynine and 7-hydroxymitragynine analysis in hair. Drug testing and analysis 12 (2) (2020)
Sabrina Lehmann, Tobias Kieliba, Mario Thevis, Markus A Rothschild, Katja Mercer-Chalmers-Bender
Fatalities associated with NPS stimulants in the Greater Cologne area. International journal of legal medicine 134 (1) (2019)
Ulf Meier, Flora Colledge, Stephan Imfeld, Thomas Briellmann, Katja Mercer-Chalmers-Bender, Eva Scheurer, Franz Dussy
Distribution pattern of common drugs of abuse, ethyl glucuronide, and benzodiazepines in hair across the scalp. Drug testing and analysis 11 (10) (2019)
Steffi Wiesenmueller, Peter Cierniak, Martin Juebner, Enrico Koerner, Dirk Hegemann, Katja Mercer-Chalmers-Bender
Tailored antimicrobial activity and long-term cytocompatibility of plasma polymer silver nanocomposites. Journal of biomaterials applications 33 (3) (2019)
Franziska Gaunitz, Tobias Kieliba, Mario Thevis, Katja Mercer-Chalmers-Bender
Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine. Drug testing and analysis 12 (1) (2019)

Katja Mercer-Chalmers-Bender.css-eqlu8i{font-size:small;padding-left:4px;} (Katja Mercer-Chalmers Bender)

Publication Activity (10 Years)

Top Topics

Top Venues

Katja Mercer-Chalmers-Bender (Katja Mercer-Chalmers Bender)